Malignant Solid Neoplasm — Trials

Malignant Solid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

900 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 429
Recruiting: 209
Ph III recruiting: 10
Growth YoY: +2.3%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (101)

clinicaltrialsPublishedShowing 351–400 of 505 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05055011	Parental Attitudes and Beliefs Regarding Risks Associated With Opioid Use in Children With Cancer	active not recruiting	—	110	M.D. Anderson Cancer CenterOTHER	1	May 4, 2026	clinicaltrials
NCT02993146	Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases	active not recruiting	Phase 1	11	National Cancer Institute (NCI)NIH	1	Apr 30, 2026	clinicaltrials